Efficacy and safety of exogenous surfactant therapy in patients under 12 months of age invasively ventilated for severe bronchiolitis (SURFABRON): protocol for a multicentre, randomised, double-blind, controlled, non-profit trial

INTRODUCTION: Some evidence indicates that exogenous surfactant therapy may be effective in infants with acute viral bronchiolitis, even though more confirmatory data are needed. To date, no large multicentre trials have evaluated the effectiveness and safety of exogenous surfactant in severe cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Biban, Paolo, Conti, Giorgio, Wolfler, Andrea Michele, Carlassara, Silvia, Gitto, Eloisa, Rulli, Immacolata, Moscatelli, Andrea, Micalizzi, Camilla, Savron, Fabio, Sagredini, Raffaella, Genoni, Giulia, Binotti, Marco, Caramelli, Fabio, Fae, Monica, Pettenazzo, Andrea, Stritoni, Valentina, D’Amato, Luigia, Zito Marinosci, Geremia, Calderini, Edoardo, Scalia Catenacci, Stefano, Berardi, Alberto, Torcetta, Francesco, Bonanomi, Ezio, Bonacina, Daniele, Ivani, Giorgio, Santuz, Pierantonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574934/
https://www.ncbi.nlm.nih.gov/pubmed/33077567
http://dx.doi.org/10.1136/bmjopen-2020-038780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574934/
https://www.ncbi.nlm.nih.gov/pubmed/33077567
http://dx.doi.org/10.1136/bmjopen-2020-038780

Ejemplares similares